Screener
Vor Biopharma VOR Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchases of marketable securities | (276,500) | — |
| Proceeds from maturities of marketable securities | 13,311 | 1 |
| Purchases of property and equipment | (48) | (231) |
| Net cash used in investing activities | (263,237) | (230) |
| Cash flows from financing activities | ||
| Payment of issuance costs related to private placement | (127) | (551) |
| Repurchases of shares for tax withholdings upon vesting of restricted stock unit awards | (2) | (55) |
| Proceeds from issuance of common stock in private placement | 74,999 | — |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's investing cash flow?
- Vor Biopharma (VOR) reported investing cash flow of -$263.24M in Q1 2026.
- How has Vor Biopharma's investing cash flow changed year-over-year?
- Vor Biopharma's investing cash flow decreased by 114350.9% year-over-year, from -$230K to -$263.24M.
- What is the long-term trend for Vor Biopharma's investing cash flow?
- Over 3 years (2021 to 2025), Vor Biopharma's investing cash flow has grown at a -18.9% compound annual growth rate (CAGR), from -$91.65M to -$48.8M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Vor Biopharma's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude